Nyron J. Persaud

Cooley advised Thirty Madison, a specialty healthcare company offering high-quality virtual specialized care for patients experiencing a range of conditions, on its definitive agreement to be acquired by Remedy Meds in an all-stock transaction valued in excess of $500 million.

Cooley advised Contentsquare, an all-in-one experience intelligence platform, on its definitive agreement to acquire Loris AI, a conversation intelligence platform, to give business leaders a deeper, more accurate view of the full customer journey – from click to conversation.

Cooley advised Movable Ink, an artificial intelligence-powered personalized content platform, on its definitive agreement to be acquired by STG. The transaction is expected to close in July 2025.

Cooley advised Nuclei in its sale to Proofpoint, a leading cybersecurity and compliance company. Nuclei is a US-based technology company specializing in compliance archiving and artificial intelligence-driven data enrichment for modern workplace communications. Partner Ariel Rom led the Cooley team advising Nuclei.